Non-duplicate isolates from blood, urine and respiratory specimens. Interpreted according to CLSI.
There is no interpretative criteria for Sulperazon in CLSI standard.
Nitrofurantoion susceptibility test performed on urine isolates only.
For All Units (execpt ICU/DHU): Overall prevalence of extended-spectrum β-lactamases (ESBL) were 28% for E.coli, 13% for Klebsiella species. ESBL-producing strains should be interpreted as resistant to all penicillins, cephalosporins and aztreonam.
% of Methicillin resistant Staphylococcus aureus among Staphylococcus aureus isolated from blood, urine and respiratory specimens: 56% in non-ICU & -HDU and 28% in ICU & HDU.
Adult Intensive Care Units and High Dependency Unit : Overall prevalance of extended-spectrum β-lactamases (ESBL) were 30% for E.coli, 13% for Klebsiella species. ESBL-producing strains should be interpreted as resistant to all penicillins, cephalosporins and aztreonam.
For staphylococci that test susceptible, gentamicin is used only in combination with other active agents that test susceptible.
Overall prevalance of extended-spectrum β-lactamases (ESBL) were 32% for E.coli (33% in the group ≧ 3d of adm, 32% in the group within ≦ 2d of adm). ESBL-producing strains should be interpreted as resistant to all penicillins, cephalosporins and aztreonam.
Overall prevalance of extended-spectrum β-lactamases (ESBL) were 9% for Klebsiella pneumoniae complex (0% in the group ≧ 3d of adm, 10% in the group within ≦ 2d of adm). ESBL-producing strains should be interpreted as resistant to all penicillins, cephalosporins and aztreonam.
Staphylococcus aureus include both Methicillin sensitive and Methicillin resistant Staphylococcus aureus.
Previous Page